Encompass Health Corporation (NYSE:EHC) Raises Dividend to $0.21 Per Share

Posted by Francis Steltz on Jul 24th, 2026

Encompass Health Corporation (NYSE:EHC – Get Free Report) announced a quarterly dividend on Thursday, July 23rd. Stockholders of record on Thursday, October 1st will be given a dividend of 0.21 per share on Thursday, October 15th. This represents a c) annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Thursday, October 1st. This is a 10.5% increase from Encompass Health’s previous quarterly dividend of $0.19.

Encompass Health has decreased its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 2 years. Encompass Health has a dividend payout ratio of 13.6% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Encompass Health to earn $6.45 per share next year, which means the company should continue to be able to cover its $0.76 annual dividend with an expected future payout ratio of 11.8%.

Encompass Health Stock Up 0.1%

NYSE:EHC opened at $111.09 on Friday. The company has a market cap of $11.02 billion, a price-to-earnings ratio of 18.55, a price-to-earnings-growth ratio of 2.42 and a beta of 0.74. Encompass Health has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The stock has a fifty day simple moving average of $104.85 and a 200-day simple moving average of $103.74.

Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same period in the prior year, the business posted $1.37 earnings per share. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Analysts anticipate that Encompass Health will post 5.96 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. TD Cowen began coverage on Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective on the stock. Leerink Partners set a $152.00 price objective on Encompass Health in a report on Friday, May 22nd. Barclays lowered their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $143.86.

Read Our Latest Research Report on Encompass Health

Encompass Health Company Profile

(Get Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.